Medistim announces partnership with ROMA-Women Trial

5. Jun 2023

Medistim is pleased to announce its partnership with ROMA-Women, a groundbreaking cardiac surgery trial that is specifically focused on women. Historically, cardiovascular research and treatment protocols have primarily focused on men, leaving women underrepresented in…

Medistim is opening a direct sales office in China

3. Apr 2023

More than 60,000 coronary bypass procedures are performed in China annually and the number is expected to continue to grow high single digit in the years to come. Today, about 70% of these procedures are…

Annual Report 2022

31. Mar 2023

Further supported by several high-quality symposia at the largest heart surgery conferences, we achieved 44 % growth in the imaging product portfolio in 2022. And while steadily penetrating the Cardiac bypass market, we also build…

Medistim celebrates a long-standing relationship with the Japanese cardiac surgery community

2. Dec 2022

“This is very much a story of a perfect fit between Norwegian technology and Japanese quality standards. Medistim technology has been able to meet expectations of the quality driven Japanese market. There are few arenas…

New ESVS Guidelines recommend intraoperative ultrasound after CEA

19. Sep 2022

The Guidelines are set to identify luminal thrombus after flow restoration, diagnose intimal flaps and diagnose residual stenoses during surgery. The new recommendation is based on a meta-analysis by Knappich et al. 20212 that shows…

Kari E. Krogstad winner of the Arthur D. Little Nordic Life Science Award 2021

6. Apr 2022

The prize was awarded at a ceremony in Stockholm on April 4, 2022. The Arthur D. Little Nordic Life Science Award is given to a person in the Nordic region that has demonstrated outstanding management…

Annual Report 2021

30. Mar 2022

This rebound has continued throughout 2021, and Medistim has experienced strong growth in revenues due to the increase in number of CABG procedures performed. The sales growth was 17.6 % in NOK and operating profit…

Pivotal consensus statement for Medistim’s transit time flow technology (TTFM) published in Circulation

19. Oct 2021

Circulation – the official journal of the American Heart Association – and one of the highest ranked journals in cardiology and cardiovascular medicine, published a consensus paper by 19 of the world’s highest renowned specialists…

Adding the popular Pay Per Procedure business model to the MiraQ platform

8. Jun 2021

Medistim utilizes several business models to effectively reach different segments of the US market. In addition to traditional capital investments and purchase of consumables, hospitals can choose to enter leasing agreements or Pay Per Procedure…

Annual Report 2020

29. Mar 2021

Following a good start to the year, Medistim experienced a significant impact on operations in the first months of the pandemic. However, due to a solid revenue base and good pipeline activity throughout the second…

Name of cookie	Time of storage	Provider	Description
_ga	2 years	medistim.com	This cookie registers your unique ID upon your visit, to generate statistical data on how you use our website.
_gat	1 day	medistim.com	This cookie is used by Google Analytics to throttle the request rate.
_gid	1 day	medistim.com	This cookie registers a unique ID that is used to generate statistical data on how you use our website.
p.gif	Session	typekit.net	This cookie keeps track of special fonts used on the site for internal analysis. This cookie does not register any visitor data.

Name of cookie	Time of storage	Provider	Description
ads/ga.audiences	Session	google.com	This cookie is used by Google Adwords to re-engage visitors that are likely to convert to customers based on the visitor's online behaviour across websites
r/collect	Session	doubleclick.net	This cookie is used to send data to Google Analytics about the visitor's device and behavior. The cookie tracks visitors across devices and marketing channels.